6,000
Participants
Start Date
March 1, 2024
Primary Completion Date
February 28, 2034
Study Completion Date
February 28, 2035
Observational Study
No Treatment or Intervention Provided
UT Southwestern Medical Center, Dallas
University of Texas Southwestern Medical Center
OTHER